Literature DB >> 9932107

Requirements for enhanced transgene expression by untranslated sequences from the human cytomegalovirus immediate-early gene.

R D Simari1, Z Y Yang, X Ling, D Stephan, N D Perkins, G J Nabel, E G Nabel.   

Abstract

BACKGROUND: The cytomegalovirus immediate early (CMV IE) promoter has been widely used for heterologous expression. Further enhancements of gene expression from this potent promoter may allow for the development of improved gene transfer strategies. We aimed to determine whether inclusion of the first exon (5' untranslated) and first intron of the CMV IE gene would increase heterologous transgene expression in primary target cells and to determine the sequences required for any observed increases.
MATERIALS AND METHODS: Comparisons of reporter gene expression were made following transient transfection of vascular smooth muscle cells (VSMCs) with plasmids containing the first exon and intron from the CMV IE gene or deletional mutations. Comparisons were also made using a heterologous promoter (RSV).
RESULTS: Gene expression from the CMV IE promoter was increased 5.7-fold in VSMC with the inclusion of the first exon and intron. Similar increases were seen with other target cells and from the heterologous RSV promoter. This increase was associated with an increase in steady-state mRNA. Deletion analyses demonstrated that the enhancement was dependent on the presence of the 5' portion of the first exon while deletion of large segments within the intron was associated with similar levels of expression compared with the parental plasmid.
CONCLUSIONS: Inclusion of the first exon and intron from the CMV IE gene increases expression from the CMV IE promoter. This enhancement is seen with the heterologous RSV promoter and is associated with an increase in steady-state mRNA. Deletion analyses suggest that this enhancement is associated with inclusion of sequences within the 5' portion of the first exon and inclusion of an intron.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9932107      PMCID: PMC2230344     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  22 in total

1.  Site-specific gene expression in vivo by direct gene transfer into the arterial wall.

Authors:  E G Nabel; G Plautz; G J Nabel
Journal:  Science       Date:  1990-09-14       Impact factor: 47.728

2.  A generic intron increases gene expression in transgenic mice.

Authors:  T Choi; M Huang; C Gorman; R Jaenisch
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

3.  Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter.

Authors:  G D Chapman; C S Lim; R S Gammon; S C Culp; J S Desper; R P Bauman; J L Swain; R S Stack
Journal:  Circ Res       Date:  1992-07       Impact factor: 17.367

4.  Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice.

Authors:  M J Stewart; G E Plautz; L Del Buono; Z Y Yang; L Xu; X Gao; L Huang; E G Nabel; G J Nabel
Journal:  Hum Gene Ther       Date:  1992-06       Impact factor: 5.695

5.  In vitro polyadenylation is stimulated by the presence of an upstream intron.

Authors:  M Niwa; S D Rose; S M Berget
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

6.  Enhancement of RNA polymerase II initiation complexes by a novel DNA control domain downstream from the cap site of the cytomegalovirus major immediate-early promoter.

Authors:  P Ghazal; J A Nelson
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

7.  Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis.

Authors:  E G Nabel; G Plautz; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

8.  Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries.

Authors:  G Leclerc; D Gal; S Takeshita; S Nikol; L Weir; J M Isner
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells.

Authors:  B S Chapman; R M Thayer; K A Vincent; N L Haigwood
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

10.  Heterologous introns can enhance expression of transgenes in mice.

Authors:  R D Palmiter; E P Sandgren; M R Avarbock; D D Allen; R L Brinster
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

View more
  4 in total

1.  Splicing is required for rapid and efficient mRNA export in metazoans.

Authors:  M J Luo; R Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Human α7 Integrin Gene (ITGA7) Delivered by Adeno-Associated Virus Extends Survival of Severely Affected Dystrophin/Utrophin-Deficient Mice.

Authors:  Kristin N Heller; Chrystal L Montgomery; Kimberly M Shontz; K Reed Clark; Jerry R Mendell; Louise R Rodino-Klapac
Journal:  Hum Gene Ther       Date:  2015-08-11       Impact factor: 5.695

3.  AAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic mice.

Authors:  Kristin N Heller; Chrystal L Montgomery; Paul Ml Janssen; K Reed Clark; Jerry R Mendell; Louise R Rodino-Klapac
Journal:  Mol Ther       Date:  2013-01-15       Impact factor: 11.454

4.  Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery.

Authors:  L G Chicoine; C L Montgomery; W G Bremer; K M Shontz; D A Griffin; K N Heller; S Lewis; V Malik; W E Grose; C J Shilling; K J Campbell; T J Preston; B D Coley; P T Martin; C M Walker; K R Clark; Z Sahenk; J R Mendell; L R Rodino-Klapac
Journal:  Mol Ther       Date:  2013-10-23       Impact factor: 11.454

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.